Study: Adjunctive Cannabis Use Improves Treatment Retention In Opioid-Dependent Subjects

Opioid-Addiction

MISSOURI: The intermittent use of cannabis can play a positive role in opioid-dependent subjects undergoing treatment, according to a review published in the journal Cannabis and Cannabinoid Research. Researchers from the Washington University School of Medicine in St. Louis assessed data evaluating the relationship between the use of cannabis and opioids. They reported, “Adjunct cannabis use alongside current treatment Read the full article…

Yom Chai Forms Strategic Partnership With Israeli Research and Development Company Kaneh-B

research

Partnership Will Conduct Scientific Clinical Trials On ADHD; Distribute Approved European Dermal Products ISRAEL:  Yom Chai has entered into a strategic partnership with Kaneh-B to co-found the development and clinical validation of a range of cannabis based ADHD products. Yom Chai’s objective is to conduct scientific trials in Israel utilizing various Cannabinoid and Terpene profiles with the goal of Read the full article…

Father of THC Dr. Raphael Mechoulam Keynotes CannX Oct 14-16 In Tel Aviv

Dr Raphael Machoulam

ISRAEL: Dr. Raphael Mechoulam, Professor of Medicinal Chemistry at The Hebrew University of Jerusalem, Israel, and the man credited with first discovering and isolating THC will keynote the 3rd International Medical Cannabis Conference (CannX), October 14-16th in Tel Aviv. Speaking on The Plant Cannabinoids And The Endocannabinoid System — An Overview Of Research Over Five Decades, Dr. Mechoulam will set Read the full article…

OLCC Marks To Address MMJ Regulatory Changes At ICBC

Steve Marks on stage at CCC

OREGON: Oregon Liquor Control Commission Executive Director Steve Marks will provide an overview of the agency’s medical marijuana tracking program and an outlook on the steps the agency is taking to balance its regulatory responsibilities while accommodating the needs of medical marijuana patients in a keynote address at the International Cannabis and Business Conference. The OLCC began Read the full article…

Ohio Department Of Commerce Awards Act Laboratories With Private Testing Lab Provisional License

MJLegal

OHIO: The Ohio Department of Commerce has announced Act Laboratories as recipient of private testing lab provision license.  The recipients of the processor provisional licenses include: PRIVATE TESTING LABORATORY PROVISIONAL LICENSE RECIPIENTS ACT Laboratories, Inc. Battelle Memorial Institute, Columbus North Coast Testing Laboratories, LLC The Ohio Department of Commerce continues to finalize the reviews of the Read the full article…

Tilray Gets DEA OK To Import Medical Cannabis Study Drug For Clinical Trial At University Of California San Diego Center For Medicinal Cannabis Research

r7_essentialtremor-8col

CANADA: Tilray has announced that the U.S. Drug Enforcement Administration (DEA) has granted approval to import a cannabinoid study drug into the United States from Canada for a clinical trial at the University of California San Diego (UC San Diego) Center for Medicinal Cannabis Research (CMCR) examining its safety, tolerability and efficacy for Essential Tremor (ET). Read the full article…

Study: Cannabis Inhalation Not Associated With COPD, Other Tobacco-Related Harms

"The long-term respiratory effects of cannabis differ from traditional smoking," authors concluded. "[C]annabis smoking does not appear to be carcinogenic."

UNITED KINGDOM: Cannabis smoke exposure, even long-term, is not positively associated with chronic obstructive pulmonary disease (COPD), lung cancer, or irreversible airway damage, according to a literature review published in the journal Breathe. British researchers reviewed nearly 20 observational studies assessing cannabis inhalation and lung health, involving over 25,000 subjects. Investigators reported that the available literature fails to support Read the full article…

Curaleaf New Jersey Launches State’s First And Only Line Of Strain Specific Pure Cannabis Vape Concentrates

NJ’s leading dispensary increases product offerings after receiving state approval

NEW JERSEY: Curaleaf New Jersey, a provider of state licensed cannabinoid-based products, today launched a new line of natural, terpene rich, strain specific, vaporable cannabis concentrates for patients of its Bellmawr dispensary. The first in New Jersey to manufacture products in this category, Curaleaf continues to set the industry standard by expanding its already-diverse medical cannabis Read the full article…